Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Medical Research
Published in: European Journal of Medical Research 1/2023

Open Access 01-12-2023 | Heart Failure | Research

Monocyte to high-density lipoprotein cholesterol ratio predicts poor outcomes in ischaemic heart failure patients combined with diabetes: a retrospective study

Authors: Qiuyu Li, Xiaolong Lin, Xiaowen Bo, Fanqi Li, Siyuan Chen, Xuguang Miao, Donghui Zhao, Jinghua Liu, Qian Fan

Published in: European Journal of Medical Research | Issue 1/2023

Login to get access

Abstract

Background

The prevalence of ischaemic heart failure (HF) continues to increase. Diabetes mellitus (DM) concomitant with ischaemic HF increases the risk of major adverse cardiovascular events (MACEs). As a promising predictor for cardiovascular diseases, the predictive value of the monocyte to high-density lipoprotein cholesterol ratio (MHR) for MACE in the ischaemic HF with DM cohort has never been investigated before.

Objective

We aimed to investigate the MHR as a predictor for MACE in ischaemic HF patients with DM who underwent percutaneous coronary intervention (PCI).

Methods

This observational study enrolled 1049 patients with ischaemic HF and DM undergoing PCI from June 2017 to June 2019. The baseline data were collected. MACEs, including all-cause mortality, nonfatal myocardial infarction, and any revascularization, were recorded within the 36-month follow-up. The characteristics and incidence of MACE were analysed in four groups stratified by the quartiles of MHR. The hazard ratio for MACE was analysed with Cox regression models. The incidence of MACE in the four groups was evaluated by Kaplan‒Meier survival analysis. Restricted cubic spline analysis was performed to determine the nonlinear correlation between the MHR and MACE.

Results

After the 36-month follow-up, 407 patients (38.8%) experienced MACEs. The incidence of MACE was significantly higher among patients in the upper MHR quartile than among those in the lower MHR quartiles (23.4% vs. 36.0% vs. 41.4% and 54.6%; P < 0.001, respectively), which was consistent with the Kaplan‒Meier survival analyses (P < 0.0001). A multivariate Cox regression model showed that the MHR was an independent risk factor for MACE after variables were adjusted (adjusted HR: 2.11; 95% CI 1.47–3.03; P < 0.001). Its predictive effects on MACE showed no interaction with hypercholesterolemia (P > 0.05).

Conclusion

The MHR was a significant and independent predictor of MACEs in ischaemic HF patients with DM undergoing PCI.
Appendix
Available only for authorised users
Literature
1.
Truby LK, Rogers JG. Advanced heart failure: epidemiology, diagnosis, and therapeutic approaches. JACC Heart Fail. 2020;8(7):523–36.PubMedCrossRef
2.
Roger VL. Epidemiology of heart failure: a contemporary perspective. Circ Res. 2021;128(10):1421–34.PubMedCrossRef
3.
Adams KF Jr, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149(2):209–16.PubMedCrossRef
4.
Chia YMF, et al. Clinical correlates and pharmacological management of Asian patients with concomitant diabetes mellitus and heart failure. Heart Fail Rev. 2018;23(3):461–8.PubMedCrossRef
5.
Dei Cas A, et al. Concomitant diabetes mellitus and heart failure. Curr Probl Cardiol. 2015;40(1):7–43.PubMedCrossRef
6.
From AM, et al. Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med. 2006;119(7):591–9.PubMedCrossRef
7.
Cleland JG, et al. The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003;24(5):442–63.PubMedCrossRef
8.
McAllister DA, et al. Incidence of hospitalization for heart failure and case-fatality among 3.25 million people with and without diabetes mellitus. Circulation. 2018;138(24):2774–86.PubMedPubMedCentralCrossRef
9.
Kannel WB, McGee DL. Diabetes and cardiovascular disease The Framingham study. JAMA. 1979;241(19):2035–8.PubMedCrossRef
10.
Bahrami H, et al. Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol. 2008;51(18):1775–83.PubMedCrossRef
11.
Gottdiener JS, et al. Predictors of congestive heart failure in the elderly: the Cardiovasc Health Study. J Am Coll Cardiol. 2000;35(6):1628–37.PubMedCrossRef
12.
Targher G, et al. In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry. Eur J Heart Fail. 2017;19(1):54–65.PubMedCrossRef
13.
Johansson I, et al. Prognostic implications of type 2 diabetes mellitus in ischemic and nonischemic heart failure. J Am Coll Cardiol. 2016;68(13):1404–16.PubMedCrossRef
14.
Daubert MA, et al. High-risk percutaneous coronary intervention is associated with reverse left ventricular remodeling and improved outcomes in patients with coronary artery disease and reduced ejection fraction. Am Heart J. 2015;170(3):550–8.PubMedCrossRef
15.
Sawada SG, et al. Effect of revascularization on long-term survival in patients with ischemic left ventricular dysfunction and a wide range of viability. Am J Cardiol. 2010;106(2):187–92.PubMedCrossRef
16.
Perera D, et al. Percutaneous revascularization for ischemic ventricular dysfunction: rationale and design of the REVIVED-BCIS2 trial: percutaneous coronary intervention for ischemic cardiomyopathy. JACC Heart Fail. 2018;6(6):517–26.PubMedCrossRef
17.
Perera D, et al. Percutaneous revascularization for ischemic left ventricular dysfunction. N Engl J Med. 2022;387(15):1351–60.PubMedCrossRef
18.
Ganjali S, et al. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol. 2018;233(12):9237–46.PubMedCrossRef
19.
Eyyupkoca F, et al. Admission monocyte/HDL ratio predicts adverse cardiac remodeling after St-elevation myocardial infarction. Rev Invest Clin. 2022;74(2):104–12.PubMed
20.
Yu R, et al. Correlation between monocyte to high-density lipoprotein ratio and major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention. Pak J Med Sci. 2021;37(3):885–9.PubMedPubMedCentralCrossRef
21.
Zhang DP, et al. An elevated monocyte-to-high-density lipoprotein-cholesterol ratio is associated with mortality in patients with coronary artery disease who have undergone PCI. Biosci Rep. 2020;40(8):BSR20201108.PubMedPubMedCentralCrossRef
22.
Sercelik A, et al. Increased monocyte to high-density lipoprotein cholesterol ratio is associated with TIMI risk score in patients with ST-segment elevation myocardial infarction. Rev Port Cardiol (Engl Ed). 2018;37(3):217–23.PubMedCrossRef
23.
Oylumlu M, et al. Monocyte to high-density lipoprotein cholesterol and lymphocyte to monocyte ratios are predictors of in-hospital and long-term mortality in patients with acute coronary syndrome. Int J Clin Pract. 2021;75(5):e13973.PubMedCrossRef
24.
Li C, et al. The monocyte to high-density lipoprotein cholesterol ratio and outcomes in type 2 diabetes mellitus patients with non-ST-segment elevation acute coronary syndrome. Ann Transl Med. 2021;9(21):1627.PubMedPubMedCentralCrossRef
25.
Villanueva DLE, et al. Monocyte to high-density lipoprotein ratio (MHR) as a predictor of mortality and major adverse cardiovascular events (MACE) among ST elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention: a meta-analysis. Lipids Health Dis. 2020;19(1):55.PubMedPubMedCentralCrossRef
26.
Liu HT, et al. Monocyte to high-density lipoprotein ratio predict long-term clinical outcomes in patients with coronary heart disease: a meta-analysis of 9 studies. Medicine (Baltimore). 2022;101(33):e30109.PubMedCrossRef
27.
Sun M, et al. Prognostic utility of monocyte to high-density lipoprotein ratio in patients with acute coronary syndrome: a meta-analysis. Am J Med Sci. 2020;359(5):281–6.PubMedCrossRef
28.
Wang R, et al. Application value of systemic inflammatory indexes in the clinical evaluation of patients with heart failure with preserved ejection fraction (HFpEF). Medicina (Kaunas). 2022;58(10):1473.PubMedCrossRef
29.
Liu Z, et al. Associations of systemic inflammatory markers with the risks of chronic heart failure: a case-control study. Clinics (Sao Paulo). 2022;77:100056.PubMedCrossRef
30.
Zhong J, et al. Monocyte to high-density lipoprotein cholesterol ratio is associated with subclinical left cardiac remodeling and dysfunction in type 2 diabetes mellitus. Int Heart J. 2022;63(3):524–30.PubMedCrossRef
31.
Mayasari DS, et al. Association of monocyte-to-high density lipoprotein ratio with arterial stiffness in patients with diabetes. BMC Cardiovasc Disord. 2021;21(1):362.PubMedPubMedCentralCrossRef
32.
Völz S, et al. Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J. 2021;42(27):2657–64.PubMedPubMedCentralCrossRef
33.
Alfonso F, et al. Current treatment of in-stent restenosis. J Am Coll Cardiol. 2014;63(24):2659–73.PubMedCrossRef
34.
Sianos G, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1(2):219–27.PubMed
35.
Chinese Society of Cardiology, Chinese Medical Association, Editorial Board of Chinese Journal of Cardiology. Chinese guideline for percutaneous coronary intervention in patients with left main bifurcation disease. Zhonghua Xin Xue Guan Bing Za Zhi. 2022;50(4):349–60.
36.
Thygesen K, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231–64.PubMedCrossRef
37.
Zhou M, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;394(10204):1145–58.PubMedPubMedCentralCrossRef
38.
Fihn SD, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2014;130(19):1749–67.PubMedCrossRef
39.
Kratofil RM, et al. Monocyte conversion during inflammation and injury. Arterioscler Thromb Vasc Biol. 2017;37(1):35–42.PubMedCrossRef
40.
41.
42.
Murphy AJ, et al. High-density lipoprotein: a potent inhibitor of inflammation. Clin Exp Pharmacol Physiol. 2010;37(7):710–8.PubMedCrossRef
43.
44.
Xepapadaki E, et al. Τhe antioxidant function of HDL in atherosclerosis. Angiology. 2020;71(2):112–21.PubMedCrossRef
45.
Xiang Y, et al. Lower HDL-C levels are associated with higher expressions of CD16 on monocyte subsets in coronary atherosclerosis. Int J Med Sci. 2020;17(14):2171–9.PubMedPubMedCentralCrossRef
46.
Nazir S, et al. Interaction between high-density lipoproteins and inflammation: Function matters more than concentration! Adv Drug Deliv Rev. 2020;159:94–119.PubMedCrossRef
47.
48.
Çiçek G, et al. The relationship between admission monocyte HDL-C ratio with short-term and long-term mortality among STEMI patients treated with successful primary PCI. Coron Artery Dis. 2016;27(3):176–84.PubMedCrossRef
49.
Karataş MB, et al. Monocyte to high-density lipoprotein ratio as a new prognostic marker in patients with STEMI undergoing primary percutaneous coronary intervention. Am J Emerg Med. 2016;34(2):240–4.PubMedCrossRef
50.
Açıkgöz SK, et al. Monocyte to high-density lipoprotein cholesterol ratio is predictive of in-hospital and five-year mortality in ST-segment elevation myocardial infarction. Cardiol J. 2016;23(5):505–12.PubMed
51.
Zhang Y, et al. Is monocyte to HDL ratio superior to monocyte count in predicting the cardiovascular outcomes: evidence from a large cohort of Chinese patients undergoing coronary angiography. Ann Med. 2016;48(5):305–12.PubMedCrossRef
Metadata
Title
Monocyte to high-density lipoprotein cholesterol ratio predicts poor outcomes in ischaemic heart failure patients combined with diabetes: a retrospective study
Authors
Qiuyu Li
Xiaolong Lin
Xiaowen Bo
Fanqi Li
Siyuan Chen
Xuguang Miao
Donghui Zhao
Jinghua Liu
Qian Fan
Publication date
01-12-2023
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-023-01451-6

Other articles of this Issue 1/2023

European Journal of Medical Research 1/2023 Go to the issue

Research

Respiratory viruses and postoperative hemodynamics in patients with unrestrictive congenital cardiac communications: a prospective cohort study

Research

Expression of microRNAs in leukocytes and serum of asbestosis patients

Correction

Correction: Systematic oxidative stress indices predicts prognosis in patients with urothelial carcinoma of the upper urinary tract after radical nephroureterectomy

Review

Anakinra for the treatment of COVID-19 patients: a systematic review and meta-analysis

Research

A new, alternative risk score for sarcopenia in Chinese patients with type 2 diabetes mellitus

Research

A nomogram for predicting the risk of new vertebral compression fracture after percutaneous kyphoplasty